CURRICULUM VITAE. II. EDUCATIONAL BACKGROUND 2.1. Program: Bachelor Master Doctoral 2.2. University AIRLANGGA UNIVERSITY AIRLANGGA UNIVERSITY

Size: px
Start display at page:

Download "CURRICULUM VITAE. II. EDUCATIONAL BACKGROUND 2.1. Program: Bachelor Master Doctoral 2.2. University AIRLANGGA UNIVERSITY AIRLANGGA UNIVERSITY"

Transcription

1 CURRICULUM VITAE I. PERSONAL INFORMATION Full name MIA RATWITA ANDARSINI 2. Rank PENATA / III c 3. Positions LECTOR 4. Address NGAGEL MADYA UTARA 2/3, SURABAYA 5. Telephone/Fax / miaratwita_spa@yahoo.com II. EDUCATIONAL BACKGROUND 2. Program: Bachelor Master Doctoral 2.2. University AIRLANGGA UNIVERSITY AIRLANGGA UNIVERSITY Name of university (year year) ( ) ( ) 2.3. Discipline MEDICAL PEDIATRICIAN III. AWARDS Number Years Name of Awards From

2 IV. ACADEMIC SERVICES Teaching: Pediatric Hematology Oncology (undergraduate, master) 2. Leukemia (undergraduate) 3. Bleeding disorder (undergraduate, master) 4. Anemia (undergraduate, master) 5. Modul Laboratory Approach (undergraduate) 6. Modul Laboratory Diagnostic (undergraduate) 7. Medical skill (undergraduate) Graduated Advisees: - Undergraduate : 3 students - Master : 15 students - Doctoral : - students Advising: - Undergraduate : 3 students - Master : 13 students - Doctoral : - students V. RESEARCH INTERESTS Pediatric Hematology Oncology VI. RESEARCH EXPERIENCE No. Years Title 2014 Ekspresi survivin pada Leukemia Limfoblastik Akut (LLA) Anak Sebagai Penyebab Perbedaan Luaran Kemoterapi fase induksi serta Pengaruhnya pada Siklus Sel Ekspresi Heat shock Protein (HSP) 27 pada Leukemia Limfoblastik Akut (LLA) Anak Sebagai Penyebab Perbedaan Luaran Kemoterapi fase induksi serta Pengaruhnya pada Apoptosis Sel Funding Sources Amount (in Rupiah) BOPTN UNAIR BOPTN UNAIR

3 VII. PUBLIC SERVICES EXPERIENCES No. Years Title Sources Funding Amount (in Rupiah) VIII. ACADEMIC PUBLICATIONS No. Year Title Volume (Issue) Journals A. International Journals Published 2. B. National Journals Published 2010 Antibiotic Resistance Control Program in Pediatric Hematology Oncology Patients at Dr Soetomo Hospital in Hepatitis Virus Infection in Repeatedly Transfused Thalassemia Patients Correlation between Initial Absolute Lymphocyte Count and the Development of Chronic Immune Thrombocytopenic Purpura Remission Rate of Induction Phase between Prednisone and Dexamethasone on Indonesian Standard Risk Acute Lymphoblastic Leukemia Protocol Langerhan s Cell Histiocytosis in Neonate (a Case Report) Cutaneous Involvement of Acute Lymphoblastic Leukemia-L1 type at Maintenance Phase of Chemoterapy in a Child (A Case Report) Early Deaths and Treatment-Relaed Deaths in Childhood Acute Lymphoblastic Leukemia in Dr Soetomo Hospital during Vol 1 No 2 Vol 2 No 1 Indonesian Journal of Tropic and Infectious Disease Indonesian Journal of Tropic and Infectious Disease

4 Hairy Cell Leukemia in a Child 9.Who Was First Diagnosed as Acute Lymphoblastic Leukemia L2- type (A Case Report) Unusual Clinical Manifestation of Medulloblastoma in a Child (A Case Report) Bacterial and Antibiotic Sensitivity Test in Pediatric Hematology Oncology Patients with Bacteremia during January June 2010 at Dr Soetomo Hospital HIV Infection in Hb E Thalassemia Child (A Case Report) Prognostic Factors of Mortality in Children with High Risk of Acute Lymphoblastic Leukemia in Dr Soetomo Hospital Misinterpretation of Calcification Feature on Multislice Computed Tomography Angiography in an Infant with Cavernous Hemangioma (Case Report) Relapse Pattern in Childhood Acute Lymphoblastic Leukemia treated with Standard Risk Indonesian ALL Protocol Risk Factor of Relapse in Childhood Acute Lymphoblastic Leukemia treated with Indonesian Acute Lymphoblastic Leukemia Protocol 2006 in Dr Soetomo Hospital Predictor of Mortality in Children with Acute Lymphoblastic Leukemia treated with Standard Risk Indonesian Acute Lymphoblastic Leukemia Protocol Acute Kidney Injury as Early Complication of Acute Lymphoblastic Leukemia-L1 type in a three-year old Girl (a Case report) Leptomeningeal Metastasis in a child with Acute Lymphoblastic Leukemia (a Case report)

5 Prognostic Factor of Mortality in Children with Retinoblastoma Genetic Polymorphism in Relapse of Acute Lymphoblastic Leukemia Clinical Presentation and Outcome of childhood Acute Myeloid Leukemia at Dr Soetomo Hospital Outcome of Combined Treatment in Children with Intraoccular Retinoblastoma at Dr Soetomo Hospital Efficacy of Exchange Transfusion and Alkalinization for Hyperleukocytosis in Acute Leukemia Risk Factor of Mortality in Children with Wilm s Tumor Bacterial Infection and Mortality in Acute Lymphoblastic Leukemia with Febrile Neutropenia Methylene Tetrahydrofolate Reductase Gene Polymorphism in Children with Acute Lymphoblastic Leukemia Relapse at Dr Soetomo Hospital Cardiac Involvement in Patients with Thalassemia major assesed with Echocardiography Pheripheral Neuropathy in a Child with Non Hodgkin Lymphoma : a Case Reporti High Dose of rfviiia in Management of Pseudotumor in a Child with Hemophilia A and High Titer Inhibitor : a Case Report Transcatheter Arterial Chemoembolization in a Child with Hepatoblastoma Management Hypertension in Children with Wilm s Tumor; a Case Series Risk Factor of Severity in β Thalassemia Multiple Glomus Tumor : a Case Report

6 Prenatal diagnosis in a family with HbE/β Thalassemia at Dr Soetomo Hospital Clinical Profile of Patient with Hemophilia at Dr Soetomo Hospital A Two month-old Girl with Extraoccular Retinoblastoma Castleman disease : a Case Report C. Under Review D. International Conferences 1 IX. MEMBERSHIP IDI, since IDAI, since POI, since 2010 X. RESEARCH SERVICES

7 XI. BOOKS No. Year Title Number of Pages 2. Publisher Semua data yang saya isikan dan tercantum dalam biodata ini adalah benar dan dapat dipertanggung jawabkan secara hukum. Dan apabila dikemudian hari ternyata dijumpai ketidak sesuaian dengan kenyataan, saya sanggup menerima resikonya. Surabaya, 9 Februari 2016 Mengetahui, Ketua Departemen Menyatakan, Dosen Dr. Hari Kushartono, dr,spa(k) Mia Ratwita Andarsini,dr.,SpA(K) NIP NIP

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug

More information

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:

More information

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

Index. Note: Page numbers of article numbers are in boldface type.

Index. Note: Page numbers of article numbers are in boldface type. Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal

More information

Hematology/Oncology/BMT

Hematology/Oncology/BMT The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,

More information

Proceeding of Surabaya International Health Conference July 13-14, 2017

Proceeding of Surabaya International Health Conference July 13-14, 2017 PHASE OF CHEMOTHERAPY WITH NUTRITIONAL STATUS OF CHILDREN WITH LEUKEMIA AT ROOM BONA 2 DR. SOETOMO HOSPITAL Kiaonarni Ongko Waluyo, Adin Mu'afiro, Irine Christiany Nursing Department Health Polytechnic

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians.

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians. Dr. Robert Reid Cabral Children s Hospital Dominican Republic Brief Description of the Hematology-Oncology Service Palliative Care Pilot Program and Metronomic Therapy Dr. Robert Reid Cabral Children's

More information

Pediatric cancer. Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital

Pediatric cancer. Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital Pediatric cancer เทคน คการให รห สโรค Siriraj Cancer ICD-O Registry ฉบ บม ออาช พ Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital Different

More information

Strategies for the Treatment of Elderly DLBCL Patients, New Combination Therapy in NHL, and Maintenance Rituximab Therapy in FL

Strategies for the Treatment of Elderly DLBCL Patients, New Combination Therapy in NHL, and Maintenance Rituximab Therapy in FL New Evidence reports on presentations given at ASH 2009 Strategies for the Treatment of Elderly DLBCL Patients, New Combination Therapy in NHL, and Maintenance Rituximab Therapy in FL From ASH 2009: Non-Hodgkin

More information

Past Chapter Summaries Educational Topics Summary

Past Chapter Summaries Educational Topics Summary Below is a comprehensive summary of all of the different Educational Topics our Local Chapters have presented and/or provided 2014 1. The most powerful force in nursing 2. Hope and meaning in life in adolescent

More information

TABLE OF CONTENT. COVER... i. SUPERVISOR APPROVAL SHEET... ii. DETERMINATION SHEET EVALUATOR COMMITTEE RESEARCH. iii. STATEMENT OF AUNTHENTICITY...

TABLE OF CONTENT. COVER... i. SUPERVISOR APPROVAL SHEET... ii. DETERMINATION SHEET EVALUATOR COMMITTEE RESEARCH. iii. STATEMENT OF AUNTHENTICITY... TABLE OF CONTENT COVER.... i SUPERVISOR APPROVAL SHEET... ii Pages DETERMINATION SHEET EVALUATOR COMMITTEE RESEARCH. iii STATEMENT OF AUNTHENTICITY... iv PROLOGUE... v ABSTRAK... vi ABSTRACT... vii RINGKASAN...

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

Comparison of TNF-α and TGF-β Expression in Breast Cancer Tissues-with and without Axillary Lymph Node Metastasis

Comparison of TNF-α and TGF-β Expression in Breast Cancer Tissues-with and without Axillary Lymph Node Metastasis Research Article Comparison of TNF-α and TGF-β Expression in Breast Cancer Tissues-with and without Axillary Lymph Node Metastasis Ayu Tyasmara, Willy Sandhika Department of Anatomical Pathology, Universitas

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours. SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,

More information

BLUE BERRY MUFFIN BABY SYNDROME. Kunrathur, Chennai, Tamil Nadu, India

BLUE BERRY MUFFIN BABY SYNDROME. Kunrathur, Chennai, Tamil Nadu, India TJPRC: International Journal of Obstetric, Gynaecologic & Neonatal Nursing (TJPRC: IJOGNN) Vol. 1, Issue 1, Jun 2017, 17-20 TJPRC Pvt. Ltd. BLUE BERRY MUFFIN BABY SYNDROME TAMILARASI. B 1 & KANAGAVALLI.

More information

APPLICANT INFORMATION

APPLICANT INFORMATION Pediatric Hematology Oncology / Stem Cell Transplant Nurse Practitioner Graduate Fellowship Program TEXAS CHILDREN S CANCER AND HEMATOLOGY CENTER S NURSE PRACTITIONER GRADUATE FELLOWSHIP APPLICATION Mail

More information

The Development of Pediatric Oncology in Turkey:

The Development of Pediatric Oncology in Turkey: The Development of Pediatric Oncology in Turkey: Improving Childhood Cancer Survival Rate Through Professional Training and Education Prof. Dr. Tezer Kutluk, MD PhD, FAAP UICC president & Hacettepe University

More information

PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION

PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION DEPARTMENT OF PEDIATRICS NATIONAL CAPITAL CONSORTIUM PEDIATRIC RESIDENCY PROGRAM PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION February 2017 1. DURATION OF ROTATION: One (1) block/four (4) weeks. 2. ELIGIBILITY:

More information

Systematic Reviews in Hematological Malignancies

Systematic Reviews in Hematological Malignancies Systematic Reviews in Hematological Malignancies Pia Raanani, MD Davidoff Cancer Center Rabin Medical Center, Israel 1 2 Disorder CHMG Systematic review* Title Protocol Full Review Myelodysplastic syndrome

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should

More information

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving

More information

Pediatric Oncology. Vlad Radulescu, MD

Pediatric Oncology. Vlad Radulescu, MD Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common

More information

1 Introduction. 1.1 Cancer. Introduction

1 Introduction. 1.1 Cancer. Introduction Introduction 1 1.1 Cancer 1 Introduction Cancer is the most precarious disease characterized by uncontrolled proliferation of cells without any physiological demands of the organism. Cancer may be defined

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 1090-7 Program Prior Authorization/Notification Medication Revlimid (lenalidomide) P&T Approval Date 6/2009, 3/2010, 6/2010, 9/2010,

More information

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 A Practical Approach to Leukopenia/Neutropenia in Children Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 Disclosures EPIC trial MAST Therapeutics SUSTAIN trial Selexys Pharmaceuticals

More information

Acknowledgements and Disclaimer

Acknowledgements and Disclaimer Infant Cancers in California, 1988 2011 Acknowledgements and Disclaimer The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of

More information

RECOMMENDED COURSE ORDER

RECOMMENDED COURSE ORDER Although you have the flexibility to view the videos in any order, we strongly recommend that you watch the videos in the order in which your dashboard presents them regardless of how many videos you view

More information

Revlimid. Revlimid (lenalidomide) Description. Section: Prescription Drugs Effective Date: October 1, 2016

Revlimid. Revlimid (lenalidomide) Description. Section: Prescription Drugs Effective Date: October 1, 2016 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.47 Subject: Revlimid Page: 1 of 7 Last Review Date: September 15, 2016 Revlimid Description Revlimid

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

Careers in Pediatric Hematology/Oncology

Careers in Pediatric Hematology/Oncology Careers in Pediatric Hematology/Oncology Prepared by The American Society of Pediatric Hematology/Oncology ASPHO 8735 W. Higgins Rd., Suite 300, Chicago, IL 60631 847.375.4716 aspho.org ABOUT ASPHO The

More information

Easy Trick to Spot Leukemia for Pediatricians

Easy Trick to Spot Leukemia for Pediatricians Easy Trick to Spot Leukemia for Pediatricians Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital Most Common Pediatric Cancers Age 0-14 Leukemia 32%

More information

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS Contributors Reviewers Acknowledgements Preface xii xvi xvii xviii I CARDIOVASCULAR COMPLICATIONS 1 Cardiac Complications of Cancer and Anticancer Treatment 3 Introduction 3 Malignant Pericardial Effusion

More information

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver

More information

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood? What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

Mechanisms Of Viral Leukaemogenesis (Leukaemia And Lymphoma Research ; V. 1)

Mechanisms Of Viral Leukaemogenesis (Leukaemia And Lymphoma Research ; V. 1) Mechanisms Of Viral Leukaemogenesis (Leukaemia And Lymphoma Research ; V. 1) If you are searching for a ebook Mechanisms of Viral Leukaemogenesis (Leukaemia and Lymphoma Research ; V. 1) in pdf format,

More information

BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib

BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib Protocol Code Tumour Group Contact Physician ULKAMLAS Leukemia/BMT Dr. Donna Hogge ELIGIBILITY: Acute myeloid

More information

MYELODYSPLASTIC AND MYELOPROLIFERATIVE

MYELODYSPLASTIC AND MYELOPROLIFERATIVE MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISORDERS Pediatric Hemato-Oncology Division Medical Faculty University of Sumatera Utara 1 MYELODYSPLASIA SYNDROME A group of disorder defect in hematopoetic cell

More information

AWARENESS OF USING RINGER LACTAT SOLUTION IN DENGUE VIRUS INFECTION CASES could INDUCE SEVERITY

AWARENESS OF USING RINGER LACTAT SOLUTION IN DENGUE VIRUS INFECTION CASES could INDUCE SEVERITY 35 Vol. 4. No. 4 October December 2013 Case Report AWARENESS OF USING RINGER LACTAT SOLUTION IN DENGUE VIRUS INFECTION CASES could INDUCE SEVERITY Soegeng Soegijanto 1,2, Desiana W Sari 2, Atsushi Yamanaka

More information

H&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS

H&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS H&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS Each of you should have 37 new cards: 7 orange cards for antimetabolites 11 white cards for miscellaneous drugs (2 DNA synthesis inhibitors, 1 enzyme,

More information

IVIG (intravenous immunoglobulin) Bivigam, Carimune NF, Flebogamma, Gammagard, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Privigen

IVIG (intravenous immunoglobulin) Bivigam, Carimune NF, Flebogamma, Gammagard, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Privigen Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following documented indications: 1. Primary Immunodeficiency Disease (PID) with ONE of the a. Hypogammaglobulinemia,

More information

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells

More information

SEVERE HYPERCALCEMIA SEVERE HYPERCALCEMIA A RARE AND UNUSUAL PRESENTATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

SEVERE HYPERCALCEMIA SEVERE HYPERCALCEMIA A RARE AND UNUSUAL PRESENTATION OF ACUTE LYMPHOBLASTIC LEUKEMIA SEVERE HYPERCALCEMIA SEVERE HYPERCALCEMIA A RARE AND UNUSUAL PRESENTATION OF ACUTE LYMPHOBLASTIC LEUKEMIA Dr. Sowmiya Narayani. R. Junior Resident, Division Of Pediatric Hematology Oncology/ Pediatric

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.08 Subject: Leukine Page: 1 of 5 Last Review Date: September 15, 2017 Leukine Description Leukine

More information

: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate

: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate CURRICULUM VITAE NAME Hyun Woo Lee, M.D. EDUCATION 1991.3.-2001.2 : Ajou University College of Medicine, Suwon, Korea; Doctor of Medicine 2004.3-2006.2 Ajou University College of Medicine, Graduate School,

More information

Proportion of HBsAg and HBeAg Positive in Maternal Patients and Their HBsAg Positives Babies with

Proportion of HBsAg and HBeAg Positive in Maternal Patients and Their HBsAg Positives Babies with 79 Vol. 6. No. 4 January April 2017 Research Report Proportion of HBsAg and HBeAg Positive in Maternal Patients and Their Babies with Immunoprophylaxis of HBV Immunization in Dr. Soetomo General Hospital,

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

MATHEMATICS GRADUATES PERCEPTIONS ON SUITABILITY OF EMPLOYMENT USING LOGISTIC REGRESSION HEIRNIZAH MELATI BINTI JAMRI UNIVERSITI TEKNOLOGI MALAYSIA

MATHEMATICS GRADUATES PERCEPTIONS ON SUITABILITY OF EMPLOYMENT USING LOGISTIC REGRESSION HEIRNIZAH MELATI BINTI JAMRI UNIVERSITI TEKNOLOGI MALAYSIA MATHEMATICS GRADUATES PERCEPTIONS ON SUITABILITY OF EMPLOYMENT USING LOGISTIC REGRESSION HEIRNIZAH MELATI BINTI JAMRI UNIVERSITI TEKNOLOGI MALAYSIA MATHEMATICS GRADUATES PERCEPTIONS ON SUITABILITY OF EMPLOYMENT

More information

ABSTRAK Korelasi anatara Index Massa Tubuh(IMT) dan tekanan darah pada penduduk di Desa Lebih Kecamatan Gianyar

ABSTRAK Korelasi anatara Index Massa Tubuh(IMT) dan tekanan darah pada penduduk di Desa Lebih Kecamatan Gianyar ABSTRAK Korelasi anatara Index Massa Tubuh(IMT) dan tekanan darah pada penduduk di Desa Lebih Kecamatan Gianyar Obesitas dapat membuat berbagai masalah kesehatan, salah satunya adalah peningkatan tekanan

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Cancer in infancy: Experience of Children Welfare Teaching Hospital, Medical City Complex, Baghdad

Cancer in infancy: Experience of Children Welfare Teaching Hospital, Medical City Complex, Baghdad Original Article Cancer in infancy: Experience of Children Welfare Teaching Hospital, Medical City * Amir F. Al-Darraji* Raghad M. Al-saeed** Salma Al-Hadad** CABP FIBMS FICMS CABP, MRCPCH J Fac Med Baghdad

More information

Description of the evidence collection method. (1). Each recommendation was discussed by the committee and a consensus

Description of the evidence collection method. (1). Each recommendation was discussed by the committee and a consensus Special Article Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Sandra Regina Loggetto 1

More information

TKIs ( Tyrosine Kinase Inhibitors ) Mechanism of action and toxicity in CML Patients. Moustafa Sameer Hematology Medical Advsior,Novartis oncology

TKIs ( Tyrosine Kinase Inhibitors ) Mechanism of action and toxicity in CML Patients. Moustafa Sameer Hematology Medical Advsior,Novartis oncology TKIs ( Tyrosine Kinase Inhibitors ) Mechanism of action and toxicity in CML Patients Moustafa Sameer Hematology Medical Advsior,Novartis oncology Introduction In people with chronic myeloid leukemia, A

More information

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial

More information

Revlimid. Revlimid (lenalidomide) Description. Section: Prescription Drugs Effective Date: July 1, 2015

Revlimid. Revlimid (lenalidomide) Description. Section: Prescription Drugs Effective Date: July 1, 2015 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.04.47 Subject: Revlimid Page: 1 of 6 Last Review Date: June 19, 2015 Revlimid Description Revlimid (lenalidomide)

More information

Rituxan (rituximab) DRUG POLICY BENEFIT APPLICATION

Rituxan (rituximab) DRUG POLICY BENEFIT APPLICATION DRUG POLICY BENEFIT APPLICATION Rituxan (rituximab) Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib,

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral

More information

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain

More information

CURRICULUM VITAE. Sarah Dobrozsi MD

CURRICULUM VITAE. Sarah Dobrozsi MD CURRICULUM VITAE MD Assistant Professor Department of Pediatrics Division of Hematology and Oncology - Pediatrics Date of Document: October 7, 2018 OFFICE ADDRESS: MACC Fund Research Center 8701 Watertown

More information

MATHEMATICAL MODELLING OF SOME UNIFORM AND NULL- CONTEXT SPLICING SYSTEMS LIM SHUN JINN UNIVERSITI TEKNOLOGI MALAYSIA

MATHEMATICAL MODELLING OF SOME UNIFORM AND NULL- CONTEXT SPLICING SYSTEMS LIM SHUN JINN UNIVERSITI TEKNOLOGI MALAYSIA MATHEMATICAL MODELLING OF SOME UNIFORM AND NULL- CONTEXT SPLICING SYSTEMS LIM SHUN JINN UNIVERSITI TEKNOLOGI MALAYSIA MATHEMATICAL MODELLING OF SOME UNIFORM AND NULL-CONTEXT SPLICING SYSTEMS LIM SHUN JINN

More information

PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE

PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE Prof. Neelam Marwaha MD; FAMS; FISHTM. Head, Dept. of Transfusion Medicine PGIMER Chandigarh Dr. Hari Krishan Dhawan MD. Assistant

More information

Immunizing the Immunocompromised. Leilani T. Sanchez, MD, DPPS, DPIDSP Crowne Plaza Galleria Manila, 21 February 2013

Immunizing the Immunocompromised. Leilani T. Sanchez, MD, DPPS, DPIDSP Crowne Plaza Galleria Manila, 21 February 2013 Immunizing the Immunocompromised Leilani T. Sanchez, MD, DPPS, DPIDSP Crowne Plaza Galleria Manila, 21 February 2013 WHO World Health Statistics 2012 2 Immunizing the Immunocompromised Leilani T. Sanchez

More information

Treatment Of Acute Lymphocytic Leukemia (Annual Guest Lecture - Leukemia Research Fund ; 8th, 1972) By Donald Pinkel

Treatment Of Acute Lymphocytic Leukemia (Annual Guest Lecture - Leukemia Research Fund ; 8th, 1972) By Donald Pinkel Treatment Of Acute Lymphocytic Leukemia (Annual Guest Lecture - Leukemia Research Fund ; 8th, 1972) By Donald Pinkel Free Medical Textbook every people has - every people has explanation!!!!! CHAPTER 102

More information

BR for previously untreated or relapsed CLL

BR for previously untreated or relapsed CLL 1 Protocol synopsis Title Rationale Study Objectives Multicentre phase II trial of bendamustine in combination with rituximab for patients with previously untreated or relapsed chronic lymphocytic leukemia

More information

CLINICAL STUDY REPORT SYNOPSIS

CLINICAL STUDY REPORT SYNOPSIS CLINICAL STUDY REPORT SYNOPSIS Document No.: EDMS-PSDB-5412862:2.0 Research & Development, L.L.C. Protocol No.: R115777-AML-301 Title of Study: A Randomized Study of Tipifarnib Versus Best Supportive Care

More information

COURSE OUTLINE Pathophysiology

COURSE OUTLINE Pathophysiology Butler Community College Health, Education, and Public Services Division Denise LaKous Revised Spring 2014 Implemented Fall 2015 Textbook Update Fall 2015 COURSE OUTLINE Pathophysiology Course Description

More information

HYPNOPARENTING EFFECTS TOWARDS FATIGUE AS AN IMPACT OF CHEMOTHERAPY AMONG PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

HYPNOPARENTING EFFECTS TOWARDS FATIGUE AS AN IMPACT OF CHEMOTHERAPY AMONG PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA Jurnal Keperawatan Indonesia, Volume 21 No.2, Juli 2018, hal 77-83 pissn 1410-4490, eissn 2354-9203 DOI: 10.7454/jki.v21i2.570 HYPNOPARENTING EFFECTS TOWARDS FATIGUE AS AN IMPACT OF CHEMOTHERAPY AMONG

More information

CURRICULUM VITAE. National Board Certification in Pediatric Neurology, 2008

CURRICULUM VITAE. National Board Certification in Pediatric Neurology, 2008 CURRICULUM VITAE Sepideh Amouian: Child Neurologist, MD, First rank of Iranian National Board Certification in Pediatric Neurology, 2008 PERSONAL INFORMATION Name: Sepideh Amouian Sex: Female Date of birth:

More information

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist? Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Colony Stimulating Factors (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine Cancer in Children Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine 07976 608871 anant.sachdev@nhs.net Aim of this very short session! Facts and figures relating to Childrens Cancers

More information

St. Jude Trike-A-Thon Coordinator Resource Guide. Learning to. Ride. Learning to. Give. stjude.org/trike ST.

St. Jude Trike-A-Thon Coordinator Resource Guide. Learning to. Ride. Learning to. Give. stjude.org/trike ST. 2015 2016 St. Jude Trike-A-Thon Coordinator Resource Guide Learning to Ride. Learning to Give. stjude.org/trike TRIKE Your Kit includes: Coordinator Resources Coordinator Resource Guide, Posters (2), Donation

More information

Patient Name: MRN: DOB: Treatment Location:

Patient Name: MRN: DOB: Treatment Location: Page 1 of 5 I. TO (Required) This Section is required to be completed by all patients who undergo kidney transplant surgery. I hereby consent to and authorize Dr. and his/her assistant(s), including supervised

More information

Hong Kong Psychological Society Division of Counselling Psychology (DCoP) Application Form for Membership

Hong Kong Psychological Society Division of Counselling Psychology (DCoP) Application Form for Membership Hong Kong Psychological Society Division of Counselling Psychology (DCoP) Application Form for Membership You are strongly advised to read the Membership Guideline for the membership requirements before

More information

(MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE (4 WEEK) CODE DISCIPLINE THEORETIC AL

(MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE (4 WEEK) CODE DISCIPLINE THEORETIC AL OKAN UNIVERSITY FACULTY OF MEDICINE 2017 2018 ACADEMIC YEAR PHASE III COMMITTEE I (MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE 11.09.2017-06.10.2017 (4 WEEK) CODE DISCIPLINE THEORETIC

More information

Patterns of lymph node biopsy pathology at. Chris Hani Baragwanath Academic Hospital. over a period of three years Denasha Lavanya Reddy

Patterns of lymph node biopsy pathology at. Chris Hani Baragwanath Academic Hospital. over a period of three years Denasha Lavanya Reddy Patterns of lymph node biopsy pathology at Chris Hani Baragwanath Academic Hospital over a period of three years 2010-2012 Denasha Lavanya Reddy Student number: 742452 A research report submitted to the

More information

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) Leukemia AALL0932 closed after Induction Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized

More information

Cedars Sinai Medical Center Pediatric Electives

Cedars Sinai Medical Center Pediatric Electives PE 235.03 MEDICAL GENETICS COURSE CHAIR: John M. Graham, M.D., ScD.. By arrangement - Please contact the Student Coordinator 1. Counseling techniques and the approach to the patient and family with hereditary

More information

WISKOTT-ALDRICH SYNDROME. An X-linked Primary Immunodeficiency

WISKOTT-ALDRICH SYNDROME. An X-linked Primary Immunodeficiency WISKOTT-ALDRICH SYNDROME An X-linked Primary Immunodeficiency WHAT IS WISKOTT ALDRICH SYNDROME? Wiskott-Aldrich Syndrome (WAS) is a serious medical condition that causes problems both with the immune system

More information

SHORT C. V. Meletios A. Dimopoulos, MD

SHORT C. V. Meletios A. Dimopoulos, MD SHORT C. V. Meletios A. Dimopoulos, MD Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical at the National and Kapodistrian, Athens, Greece. He has been elected Vice Dean

More information

CURRICULUM VITAE. Qualification Institution Year Fellowship in Diagnostic Ultrasound.

CURRICULUM VITAE. Qualification Institution Year Fellowship in Diagnostic Ultrasound. Personal Information: Name: Dr. Angeline A. Aywak Address: P.O. Box 55218, Nairobi, Kenya. Telephone: Mobile: 0733952819/0722200803 Office: 2724722 Email: aaywakke@yahoo.com Nationality: Kenyan Marital

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

ASPHO 2019 Review Course January 31-February 2, 2019

ASPHO 2019 Review Course January 31-February 2, 2019 ASPHO 2019 Review Course January 31-February 2, 2019 ABP Content Outline Topics by Date and Speaker For additional information, see the ABP Content Outline and the ABP Content Outline with Speaker Assignments.

More information

Curriculum Vitae Hui Yuan, MD

Curriculum Vitae Hui Yuan, MD Curriculum Vitae Hui Yuan, MD Current Position: Associate Professor Department of Saint Louis University Health Sciences Center Education: 1/1978 12/1982 M.D. in Medicine Postgraduate Training: 6/1984

More information

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,

More information